Top Stories
January 2021
Adam Lorentz, MD, medical director of Emory Clinic Urology at Emory University Hospital Midtown, is one of several surgeons at the hospital that is using a new single-port robot, which is capable of using only one small incision to treat patients, thanks to improved instrumentation, camera angles, and a new design. "The single-port platform will be useful for prostate surgery as well as cancer and reconstructive operations of the kidney and bladder, as the design will allow us to offer robotic surgery to more patients who otherwise may not have been good candidates with prior robotic platforms," he says.
Vikram Narayan Presents Research at SUO 2020
December 2020
Vikram Narayan, MD, presented research on a novel intravesical gene-mediated therapy for patients with high-grade, BCG-unresponsive non-muscle invasive bladder cancer at the Annual Meeting of the Society of Urologic Oncology, held virtually December 3-5. The study found that the therapy maintained its efficacy.
Haydn Kissick Interviewed on Behind the Microscope Podcast
November 2020
Haydn Kissick, PhD, was featured on the November 24th episode of Behind the Microscope, a podcast about life in science and medicine. He discussed his personal and professional journey and what he's learned since starting his own lab.
Article by NCI Prostate Biomarker Center Group at Emory Receives Diverse Coverage
October 2020
An article authored by members of Emory University's NCI-funded Prostate Biomarker Center Investigator Group reports that fluorine (18F) fluciclovine positron emission tomography/computerized tomography (PET/CT) detects metastases better than conventional imaging in high-risk prostate cancer. The study was published in the October edition of the Journal of Urology, and its findings have been covered in such news sources as AUA Daily Scope and Urology Times.
Viraj Master Leads Study of NSAID as Potential Agent for Blocking Recurrence
August 2020
Viraj Master, MD, PhD, is principal investigator of a new pilot study of biomarker evaluation and safety of pre-incisional ketorolac for patients undergoing surgical resection for non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC). The study is funded by the Morningside Center for Innovative and Affordable Medicine, an interdisciplinary unit within the Woodruff Health Sciences Center at Emory University that seeks to promote research, education, and advocacy for effective and affordable medical treatments.
